Message from Dean Eidelman – Update on undergraduate medical education accreditation – December 2016

I remain pleased with the implementation of our Undergraduate Medical Education (UGME) accreditation plan. Our program is much stronger today, thanks to the many groups and individuals involved at all levels, including our students.
In February 2017, CACMS and LCME* will visit the Faculty to conduct a “limited site survey.” Their job will be to assess our status to date compared to their last visit in 2015. Our ultimate goal is to exceed accreditation standards over time and to continue to excel, which I have no doubt we will do. Our new MDCM curriculum is also resolving certain deficiencies identified by the accreditors, which is excellent news.
Read more ►

 

Read More Posts From This Section »

‘Heads Up on the Concussion Issue’ Public Lecture – January 27, 2017

McGill University and the Montreal Neurological Institute and Hospital (The Neuro) will host a public lecture and poster session in support of concussion research. The expert-led public lecture and panel discussion will focus on the topic of concussions. The Public Lecture begins at 7:00pm and will be held in Love Competition Hall at the McGill Sports Centre, 475 Pine Avenue.
Read more ►

 

Read More Posts From This Section »

The Rossy Cancer Network’s QI2 Quality Improvement Fund: Launching Soon!

The Rossy Cancer Network (RCN) is offering funding and project support to help you put your quality improvement ideas into action. If you work with cancer patients in a McGill-affiliated hospital and have a proposal to improve the delivery of care within a year, then QI2 is for you.
Read more ►

 

Annual Principal’s prize for public outreach through media – Nomination deadline: Feb. 6

Every year, in March, the University celebrates the excellence of its top scholars and researchers during the Bravo gala. In 2017, for the first time, McGill will be awarding two prizes at Bravo for the dissemination and popularization of research through media.
Read more ►

 

Read More Posts From This Section »

The 2015-2016 RI-MUHC Annual Report is now available online!

It is our pleasure to present the online version of the 2015-2016 Annual Report of the Research Institute of the McGill University Health Centre (RI-MUHC).
Read more ►

 

Free Hearing Screenings January 24 & 27

The School of Communication Sciences and Disorders (SCSD) is organizing once again free on campus hearing screenings. They will take place at the Centre for Interdisciplinary Research in Music Media and Technology (CIRMMT), Schulich School of Music.
Read more ►

 

MIMM Bites Newsletter – January 2017

We are pleased to announce that the first issue of 2017 is now available online. It provides news and announcements of interest to the faculty and support staff members, as well as to students and alumni members. It also presents information on department updates, upcoming events and announcements.
Read more ►

 

Read More Posts From This Section »

AmorChem spins out its USP15 Drug Discovery Platform into Corbin Therapeutics, with an initial seed investment of $1M

AmorChem is pleased to announce the creation of Corbin Therapeutics, its third spin-off company focusing on a novel therapeutic approach to treat various inflammation-based diseases via inhibition of the ubiquitin carboxyl-terminal hydrolase 15 (USP15) enzyme. The USP15 technology was developed in the laboratory of Dr. Philippe Gros, Vice-Dean, Life Sciences at McGill University, who showed the central role of USP15 in inflammation. He discovered that USP15 regulates type I interferon response and is part of the pathogenesis of neuroinflammation. The seed funding will allow Corbin to screen various compound libraries in order to identify lead candidates which efficiently inhibit the USP15 enzyme, and eventually develop them as therapies for multiple sclerosis.
Read more ►

 

McGill researchers in on 6 of 10 of Québec Science’s top discoveries

Québec Science magazine has selected its 10 Discoveries of the Year for 2016, and McGill researchers figure in six of them. The annual list highlights top scientific research from across Quebec.
Read more ►

 

Read More Posts From This Section »

A surprise advance in the treatment of adult cancers

A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of 15% of adult cancers of the throat linked to alcohol and tobacco use. This is a first in the field of epigenetics and the researchers are hopeful that the discovery can blaze a path in the development of new, targeted, more effective treatments that could arise over the next few years.
Read more ►

 

Breakthrough in MS treatment

In separate clinical trials, a drug called ocrelizumab has been shown to reduce new attacks in patients with relapsing remitting multiple sclerosis (MS), and new symptom progression in primary progressive MS. Three studies conducted by an international team of researchers, which included Amit Bar-Or and Douglas Arnold from the Montreal Neurological Institute and Hospital of McGill University, have discovered that ocrelizumab can significantly reduce new attacks in patients with relapsing MS, as well as slow the progression of symptoms caused by primary progressive MS.
Read more ►

 

Read More Posts From This Section »

McGill medical student wins Minnesota poster competition, will represent state at national competition in March

In October 2016, Frédérique St-Pierre, a fourth year medical student at McGill University participated in the poster competition at the American College of Physicians’ (ACP) Internal Medicine Chapter Meeting held in Minneapolis, Minnesota. Frédérique’s poster presented a case she saw during her elective rotation at the Mayo Clinic, in Hematology, in August 2016. She was selected as the winner of the Best Medical Student Clinical Vignette and will be representing Minnesota at the National Poster Competition in San Diego this March during the annual ACP Internal Medicine Meeting. Congratulations Frédérique and good luck in San Diego!
Read more ►

 

Christine McCusker wins Canadian Society of Allergy and Clinical Immunology Award

Dr. Christine McCusker, Associate Professor, Department of Pediatrics, McGill University and Director, Division of Allergy & Immunology, Montreal Children’s Hospital was recently honoured as the inaugural recipient of the Canadian Society of Allergy and Clinical Immunology’s (CSACI) F. Estelle R. Simons Award for Research. Congratulations Dr. McCusker!
Read more ►

 

Read More Posts From This Section »

McGill medical students design and sell calendars

Eloise Passarella, a first-year medical student at McGill was trying to come up with an idea that would combine her two passions of medicine and dance. The result is a calendar featuring medical students representing various styles of dance in medical-related environments. All profits from sales of the calendar will be donated to the National Centre for Dance Therapy of les Grands Ballets Canadiens
Read more ►

 

Read More Posts From This Section »